STAT1 deficiency redirects IFN signalling toward suppression of TLR response through a feedback activation of STAT3

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Kim, Hun Sik ^a   Kim, Dong Chan ^a   Kim, Hong Mi ^a   Kwon, Hyung Joon ^a   Kwon, Soon Jae ^a   Kang, Suk Jo ^b   Kim, Sun Chang ^b   Choi, Go Eun ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; STAT1 PROTEIN; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR;

ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DEFICIENCY; FEEDBACK SYSTEM; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; MACROPHAGE; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; FEEDBACK, PHYSIOLOGICAL; FEMALE; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; INTERLEUKIN-12; MACROPHAGES; MICE, INBRED C57BL; NF-KAPPA B; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84940188905     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13414     Document Type: Article

References (63)

1. Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723-737 (2011
2. Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969 (2008
3. Kawai, T. & Akira, S. Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity. Immunity 34, 637-650 (2011
4. Beutler, B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430, 257-263 (2004
5. Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805-820 (2010
6. Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384 (2010
7. Kawai, T. & Akira, S. TLR signaling. Cell Death Differ. 13, 816-825 (2006
8. Hu, X., Chakravarty, S. D. & Ivashkiv, L. B. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol. Rev. 226, 41-56 (2008
9. Schroder, K., Hertzog, P. J., Ravasi, T. & Hume, D. A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75, 163-189 (2004
10. Hu, X. & Ivashkiv, L. B. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 31, 539-550 (2009
11. Gonzalez-Navajas, J. M., Lee, J., David, M. & Raz, E. Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 12, 125-135 (2012
12. Shuai, K., et al. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76, 821-828 (1994
13. Darnell, J. E., Jr., Kerr, I. M. & Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421 (1994
14. Horvath, C. M. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem. Sci. 25, 496-502 (2000
15. Meraz, M. A., et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442 (1996
16. Durbin, J. E., Hackenmiller, R., Simon, M. C. & Levy, D. E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450 (1996
17. Dupuis, S., et al. Impaired response to interferon-Alpha/beta and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33, 388-391 (2003
18. Al-Muhsen, S. & Casanova, J. L. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J. Allergy Clin. Immunol. 122, 1043-1051 (2008
19. Ramana, C. V., Gil, M. P., Schreiber, R. D. & Stark, G. R. Stat1-dependent and-independent pathways in IFN-gamma-dependent signaling. Trends Immunol. 23, 96-101 (2002
20. Gil, M. P., et al. Biologic consequences of Stat1-independent IFN signaling. Proc. Natl. Acad. Sci. USA 98, 6680-6685 (2001
21. Ramana, C. V., et al. Stat1-independent regulation of gene expression in response to IFN-gamma. Proc. Natl. Acad. Sci. USA 98, 6674-6679 (2001
22. Kim, H. S. & Lee, M. S. STAT1 as a key modulator of cell death. Cell. Signal. 19, 454-465 (2007
23. Hahm, B., Trifilo, M. J., Zuniga, E. I. & Oldstone, M. B. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22, 247-257 (2005
24. Perry, S. T., Buck, M. D., Lada, S. M., Schindler, C. & Shresta, S. STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog. 7, e1001297 (2011
25. Kovarik, P., Stoiber, D., Novy, M. & Decker, T. Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation. EMBO J. 17, 3660-3668 (1998
26. Toshchakov, V., et al. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3, 392-398 (2002
27. Kim, H. S., et al. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Immunity 27, 321-333 (2007
28. Remoli, M. E., et al. IFN-beta modulates the response to TLR stimulation in human DC: involvement of IFN regulatory factor-1 (IRF-1) in IL-27 gene expression. Eur. J. Immunol. 37, 3499-3508 (2007
29. Liu, B. S., Janssen, H. L. & Boonstra, A. Type I and III interferons enhance IL-10R expression on human monocytes and macrophages, resulting in IL-10-mediated suppression of TLR-induced IL-12. Eur. J. Immunol. 42, 2431-2440 (2012
30. Lee, M. S., Kwon, H. J. & Kim, H. S. Macrophages from Nonobese Diabetic Mouse Have a Selective Defect in IFN-gamma but Not IFN-Alpha/beta Receptor Pathway. J. Clin. Immunol. 32, 753-761 (2012
31. Cousens, L. P., Orange, J. S., Su, H. C. & Biron, C. A. Interferon-Alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA 94, 634-639 (1997
32. Welte, T., et al. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc. Natl. Acad. Sci. USA 100, 1879-1884 (2003
33. Hoentjen, F., Sartor, R. B., Ozaki, M. & Jobin, C. STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood 105, 689-696 (2005
34. Hedvat, M., et al. The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors. Cancer Cell 16, 487-497 (2009
35. Heinrich, P. C., Behrmann, I., Muller-Newen, G., Schaper, F. & Graeve, L. Interleukin-6-Type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334 (Pt2), 297-314 (1998
36. Williams, L., Bradley, L., Smith, A. & Foxwell, B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J. Immunol. 172, 567-576 (2004
37. Hu, X., et al. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24, 563-574 (2006
38. Chang, E. Y., Guo, B., Doyle, S. E. & Cheng, G. Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J. Immunol. 178, 6705-6709 (2007
39. Stephanou, A., Brar, B. K., Knight, R. A. & Latchman, D. S. Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ. 7, 329-330 (2000
40. Regis, G., Pensa, S., Boselli, D., Novelli, F. & Poli, V. Ups and downs: the STAT1: STAT3 seesaw of Interferon and gp130 receptor signalling. Semin. Cell Dev. Biol. 19, 351-359 (2008
41. Hong, F., et al. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J. Clin. Invest. 110, 1503-1513 (2002
42. Ito, S., et al. Interleukin-10 inhibits expression of both interferon alpha-And interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 93, 1456-1463 (1999
43. Qing, Y. & Stark, G. R. Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J. Biol. Chem. 279, 41679-41685 (2004
44. Costa-Pereira, A. P., et al. Mutational switch of an IL-6 response to an interferon-gamma-like response. Proc. Natl. Acad. Sci. USA 99, 8043-8047 (2002
45. Nathan, C. Mechanisms and modulation of macrophage activation. Behring Inst. Mitt. 200-207 (1991
46. Mosser, D. M. The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212 (2003
47. Yu, Z., Zhang, W. & Kone, B. C. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. Biochem. J. 367, 97-105 (2002
48. Lee, H., et al. Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 15, 283-293 (2009
49. Nadiminty, N., et al. Stat3 activation of NF-? B p100 processing involves CBP/p300-mediated acetylation. Proc. Natl. Acad. Sci. USA 103, 7264-7269 (2006
50. Yu, J., et al. Noncanonical NF-kappaB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer. J. Immunol. 193, 2574-2586 (2014
51. Alexander, W. S. & Hilton, D. J. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22, 503-529 (2004
52. Song, M. M. & Shuai, K. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferonmediated antiviral and antiproliferative activities. J. Biol. Chem. 273, 35056-35062 (1998
53. Kondo, T., Kawai, T. & Akira, S. Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol. 33, 449-458 (2012
54. Auernhammer, C. J., Bousquet, C. & Melmed, S. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc. Natl. Acad. Sci. USA 96, 6964-6969 (1999
55. Li, X. D., et al. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341, 1390-1394 (2013
56. Vairo, D., et al. Severe impairment of IFN-gamma and IFN-Alpha responses in cells of a patient with a novel STAT1 splicing mutation. Blood 118, 1806-1817 (2011
57. Chang, Y. E. & Laimins, L. A. Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. J. Virol. 74, 4174-4182 (2000
58. Kubota, T., Yokosawa, N., Yokota, S. & Fujii, N. C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-Alpha. Biochem. Biophys. Res. Commun. 283, 255-259 (2001
59. Kim, H. S. & Lee, M. S. Essential role of STAT1 in caspase-independent cell death of activated macrophages through the p38 mitogen-Activated protein kinase/STAT1/reactive oxygen species pathway. Mol. Cell. Biol. 25, 6821-6833 (2005
60. Zhang, X., Goncalves, R. & Mosser, D. M. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. Chapter 14, Unit 14.1.1 (2008
61. Stetson, D. B. & Medzhitov, R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24, 93-103 (2006
62. Kim, H. S., Park, J. M. & Lee, M. S. A defect in cell death of macrophages is a conserved feature of nonobese diabetic mouse. Biochem. Biophys. Res. Commun. 421, 145-151 (2012
63. Zhang, X., Edwards, J. P. & Mosser, D. M. The expression of exogenous genes in macrophages: obstacles and opportunities. Methods Mol. Biol. 531, 123-143 (2009